AAAAAA
Results:
1-17
|
Results: 17
Authors:
Drusano, GL
Preston, SL
Owens, RC
Ambrose, PG
Citation: Gl. Drusano et al., Fluoroquinolone pharmacodynamics, CLIN INF D, 33(12), 2001, pp. 2091-2092
Authors:
Owens, RC
Tessier, P
Nightingale, CH
Ambrose, PG
Quintiliani, R
Nicolau, DP
Citation: Rc. Owens et al., Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens, INT J ANT A, 17(6), 2001, pp. 483-489
Authors:
Ambrose, PG
Grasela, DM
Grasela, TH
Passarell, J
Mayer, HB
Pierce, PF
Citation: Pg. Ambrose et al., Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections, ANTIM AG CH, 45(10), 2001, pp. 2793-2797
Authors:
Bui, KQ
Ambrose, PG
Nicolau, DP
Lapin, CD
Nightingale, CH
Quintiliani, R
Citation: Kq. Bui et al., Pharmacokinetics of high-dose meropenem in adult cystic fibrosis patients, CHEMOTHERA, 47(3), 2001, pp. 153-156
Authors:
Dudley, MN
Ambrose, PG
Citation: Mn. Dudley et Pg. Ambrose, Pharmacodynamics in the study of drug resistance and establishing in vitrosusceptibility breakpoints: ready for prime time, CURR OPIN M, 3(5), 2000, pp. 515-521
Authors:
Grant, EM
Zhong, MK
Ambrose, PG
Nicolau, DP
Nightingale, CH
Quintiliani, R
Citation: Em. Grant et al., Stability of meropenem in a portable infusion device in a cold pouch, AM J HEAL S, 57(10), 2000, pp. 992-995
Authors:
Ambrose, PG
Owens, RC
Citation: Pg. Ambrose et Rc. Owens, New antibiotics in pulmonary and critical care medicine: Focus on advancedgeneration quinolones and cephalosporins, SEM RESP CR, 21(1), 2000, pp. 19-32
Authors:
Ambrose, PG
Quintiliani, R
Citation: Pg. Ambrose et R. Quintiliani, Limitations of single point pharmacodynamic analysis, PEDIAT INF, 19(8), 2000, pp. 769-769
Authors:
Ambrose, PG
Grasela, DM
Citation: Pg. Ambrose et Dm. Grasela, The use of Monte Carlo simulation to examine pharmacodynamic variance of drugs: fluoroquinolone pharmacodynamics against Streptococcus pneumoniae, DIAG MICR I, 38(3), 2000, pp. 151-157
Authors:
Mason, EO
Lamberth, LB
Kershaw, NL
Prosser, BL
Zoe, A
Ambrose, PG
Citation: Eo. Mason et al., Streptococcus pneumoniae in the USA: in vitro susceptibility and pharmacodynamic analysis, J ANTIMICRO, 45(5), 2000, pp. 623-631
Authors:
Ambrose, PG
Owens, RC
Grasela, D
Citation: Pg. Ambrose et al., Antimicrobial pharmacodynamics, MED CLIN NA, 84(6), 2000, pp. 1431
Authors:
Owens, RC
Ambrose, PG
Citation: Rc. Owens et Pg. Ambrose, Clinical use of the fluoroquinolones, MED CLIN NA, 84(6), 2000, pp. 1447
Authors:
Ambrose, PG
Bui, KQ
Richerson, MA
Quintiliani, R
Nightingale, C
Citation: Pg. Ambrose et al., Pharmacoeconomic analysis of intravenous push vs slow infusion of beta-lactam antibiotics, CLIN DRUG I, 17(5), 1999, pp. 407-410
Authors:
Bui, KQ
Ambrose, PG
Grant, E
Nightingale, CH
Nicolau, DP
Quintiliani, R
Citation: Kq. Bui et al., Pharmacokinetics and pharmacoeconomic evaluation of ticarcillin-clavulanate administered as either continuous or intermittent infusion with once-daily gentamicin, INF DIS C P, 8(9), 1999, pp. 449-455
Authors:
Ambrose, PG
Richerson, MA
Stanton, ME
Bui, K
Nicolau, DP
Nightingale, CH
Quintiliani, R
Citation: Pg. Ambrose et al., Cost-effectiveness analysis of cefepime compared with ceftazidime in intensive care unit patients with hospital-acquired pneumonia, INF DIS C P, 8(5), 1999, pp. 245-251
Authors:
Richerson, MA
Ambrose, PG
Bui, KQ
Grant, E
Nicolau, DP
Nightingale, CH
Quintiliani, R
Citation: Ma. Richerson et al., Pharmacokinetic and economic evaluation of piperacillin/tazobactam administered as either continuous or intermittent infusion with once-daily gentamicin, INF DIS C P, 8(4), 1999, pp. 195-200
Continuous vs. intermittent infusion of cefuroxime for the treatment of community-acquired pneumonia
Authors:
Ambrose, PG
Quintiliani, R
Nightingale, CH
Nicolau, DP
Citation: Pg. Ambrose et al., Continuous vs. intermittent infusion of cefuroxime for the treatment of community-acquired pneumonia, INF DIS C P, 7(9), 1998, pp. 463-470
Risultati:
1-17
|